Citation: D. Butzbach et al., Can extraprostatic extension be treated by prostate brachytherapy? An analysis based on postimplant dosimetry, INT J RAD O, 51(5), 2001, pp. 1196-1199
Citation: Fm. Waterman et Ap. Dicker, The impact of postimplant edema on the urethral dose in prostate brachytherapy, INT J RAD O, 47(3), 2000, pp. 661-664
Citation: Fm. Waterman et Ap. Dicker, Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan, MED PHYS, 27(3), 2000, pp. 448-451
Authors:
Yue, N
Chen, Z
Peschel, R
Dicker, AP
Waterman, FM
Nath, R
Citation: N. Yue et al., Optimum timing for image-based dose evaluation of I-125 and (PD)-P-103 prostate seed implants, INT J RAD O, 45(4), 1999, pp. 1063-1072
Authors:
Valicenti, RK
Sweet, JW
Hauck, WW
Hudes, RS
Lee, T
Dicker, AP
Waterman, FM
Anne, PR
Corn, BW
Galvin, JM
Citation: Rk. Valicenti et al., Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer, INT J RAD O, 44(4), 1999, pp. 931-935
Authors:
Yue, N
Dicker, AP
Corn, BW
Nath, R
Waterman, FM
Citation: N. Yue et al., A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of I-125 or Pd-103 seed implant of prostate, INT J RAD O, 43(2), 1999, pp. 447-454
Authors:
Yu, Y
Anderson, LL
Li, ZF
Mellenberg, DE
Nath, R
Schell, MC
Waterman, FM
Wu, A
Blasko, JC
Citation: Y. Yu et al., Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medicine Task Group No. 64, MED PHYS, 26(10), 1999, pp. 2054-2076